PUBLISHER: Polaris Market Research | PRODUCT CODE: 1786944
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1786944
The global nutrigenomics market size is expected to reach USD 2,334.89 million by 2034, according to a new study by Polaris Market Research. The report "Nutrigenomics Market Size, Share, Trends, Industry Analysis Report: By Product (Reagents & Kits and Services), By Application, By Technique, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The nutrigenomics industry involves the study of how an individual's genetic makeup interacts with nutrients and dietary components to influence their health. This field aims to create personalized nutrition plans and products tailored to an individual's unique genetic information. By understanding these gene-nutrient interactions, nutrigenomics seeks to optimize health, prevent diseases, and manage existing chronic conditions more effectively than traditional, generalized dietary advice. It integrates insights from genomics, nutrition, and molecular biology to offer highly specific recommendations for diet and lifestyle.
There is a growing global awareness among consumers about personalized health and wellness, moving away from "one-size-fits-all" approaches to diet. People are increasingly seeking customized solutions that consider their individual biological makeup. This trend is amplified by advancements in genetic testing technologies, which have made it easier and more affordable to access personal genetic analysis information, which drives the nutrigenomics market growth. Furthermore, the rising prevalence of chronic diseases worldwide, such as obesity, diabetes, and cardiovascular conditions, is also fueling demand. Nutrigenomics offers a promising avenue for preventive healthcare and improved disease management by providing targeted dietary interventions based on an individual's genetic predispositions.
By application, the obesity segment held the largest share in 2024 due to the widespread global prevalence of obesity and the increasing consumer demand for personalized and effective weight management strategies that leverage individual genetic information.
By product, the reagents & kits segment held the largest share in 2024 as these products are fundamental to performing nutrigenomic analysis. They provide the essential tools, such as DNA extraction kits and genotyping kits, that enable individuals and laboratories to collect and process genetic samples for personalized nutritional insights, underpinning the entire industry.
By technique, saliva collection held the largest share in 2024 due to its noninvasive and highly convenient nature. This method allows for easy at-home sample collection, removing the need for clinical visits and making genetic testing more accessible to a broader consumer base, thus contributing significantly to its widespread adoption.
By end use, the hospitals & clinics segment held the largest share in 2024 as these traditional healthcare settings are increasingly integrating nutrigenomic insights into mainstream patient care.
By Region, North America held the largest share of the global nutrigenomics market in 2024. This is driven by high consumer awareness of personalized health, a robust healthcare infrastructure, and significant investments in genomic research.
Asia Pacific is emerging as a rapidly expanding region in the global market. This growth is primarily driven by rising disposable incomes, increasing health consciousness among the population, and a growing burden of lifestyle-related diseases such as obesity and diabetes.
A few key players in the market include Nutrigenomix, Metagenics, Xcode Life, GX Sciences (Fagron), dnalife, Genova Diagnostics, Holistic Health International, Vitagene, and Mapmygenome.
Polaris Market Research has segmented the nutrigenomics market report on the basis of application, product, technique, end use, and region:
By Application Outlook (Revenue - USD Million, 2020-2034)
Obesity
Cardiovascular Diseases
Cancer Research
Others
By Product Outlook (Revenue - USD Million, 2020-2034)
Reagents & Kits
Services
By Technique Outlook (Revenue - USD Million, 2020-2034)
Saliva
Buccal Swab
Blood
By End Use Outlook (Revenue - USD Million, 2020-2034)
Hospitals & Clinics
Others
By Regional Outlook (Revenue - USD Million, 2020-2034)
North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America